Abstract
There is a growing need to curate the overwhelming amount of sequencing data which is available in many public databases. For instance, new information shows that the M235T polymorphism at the angiotensinogen gene (AGT) is actually positioned at the position corresponding to the amino acid 268 and not 235. This polymorphism is filled as rs699 in the NCBI SNP database and results in the synthesis of a threonine (T) instead of a methionine (M). It has been widely studied and associated as an important risk factor for several vascular and neuropsychiatric conditions. We faced this new situation during the targeted sequencing of 360 chromosomes from Brazilian subjects studied for the M235T polymorphism, leading to the identification of a novel variation (rs141900991). This report explores the potential impact of such a dinucleotide variation, which promotes the change of alanine (A) to serine (S) at the AGT protein structure (A237S). Considering the previous M268T variation at the four possible haplotypes combined (MA, MS, TA and TS), we performed a comparative hydrophobicity simulation, using the Kyte–Doolittle algorithm, available at the CLB Bio workbench, in the four possible haplotypes. Additional simulations were performed using the programs PolyPhen, I-Mutant and SIFT, in order to evaluate the pathogenicity of both mutations. The predicted hydrophobicity decreases of a similar magnitude, with both MS and TA haplotypes, but the presence of both variations induces a major decrease in hydrophobicity, suggesting a cumulative effect, with possible modifying effect since that this variation per se would limit the hydrophobicity range and the latter chances in finding significant phenotype differences. A better characterization of this kind of variant is particularly important because the current genome wide scan analyses in complex disorders with cardiac or neural etiology are not generating reliable findings, especially if we consider the huge investment with such approach. Additional and unknown variations like this one, with potential modifying effect, might be more common than previously expected.
References
Brenner D, Labreuche J, Poirier O, Cambien F, Amarenco P, GENIC Investigators (2005) Renin–angiotensin–aldosterone system in brain infarction and vascular death. Ann Neurol 58:131–138
Couzin-Frankel J (2010) Major heart disease genes prove elusive. Science 328:1220–1221
Hu Z, Miao X, Ma H et al (2005) Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population. Int J Cancer 10:455–460
Knox SS, Guo X, Zhang Y, Weidner G, Williams S, Ellison RC (2010) AGT M235T genotype/anxiety interaction and gender in the HyperGEN study. PLoS One 5:13353
Kuznetsova T, Staessen JA, Thijs L et al (2004) European Project On Genes in Hypertension (EPOGH) Investigators: Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion. Circulation 110:2644–2650
McClellan J, King MC (2010) Genetic heterogeneity in human disease. Cell 141:210–217
Meira-Lima IV, Pereira AC, Mota GF, Krieger JE, Vallada H (2000) Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorder in humans. Neurosci Lett 293:103–106
Nakajima T, Jorde LB, Ishigami T et al (2002) Nucelotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet 70:108–123
Nakase T, Mizuno T, Harada S et al (2007) Angiotensinogen gene polymorphism as a risk factor for ischemic stroke. J Clin Neurosci 14:943–947
Procopciuc LM, Sitar-Tăut A, Pop D, Sitar-Tăut DA, Olteanu I, Zdrenghea D (2010) Renin angiotensin system polymorphisms in patients with metabolic syndrome (MetS). Eur J Intern Med 21:414–418
Rosenfeld JA, Malhota AK, Lencz T (2010) Novel multi-nucleotide polymorphisms in human genome characterized by whole genome and exome sequencing. Nucleic Acids Res 38:6102–6111
Van Rijn MJ, Bos MJ, Isaacs A et al (2007) Polymorphisms of the renin–angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology. J Neurol Neurosurg Psychiatry 78:1083–1087
Watkins WS, Hunt SC, Williams GH et al (2010) Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes. J Hypertens 28:65–75
Acknowledgments
This study was supported by grants from the following Brazilian funding agencies and academic bureaus: FACEPE (PPSUS-APQ-2008), CNPq, PROPESQ-UFPE, PIBIC-UFPE and CAPES. We are indebted to Dr. Hua Zhang, PhD, from the dbSNP Group (NCBI/NLM/NIH) for technical support during the course of this study. We also thank Dr. Aaron Rowe for revising the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
R. R. Lemos, S. G. de Lima and J. E. Gomes da Cunha contributed equally to this work.
Rights and permissions
About this article
Cite this article
Lemos, R.R., de Lima, S.G., da Cunha, J.E.G. et al. Revising the M235T Polymorphism Position for the AGT Gene and Reporting a Modifying Variant in the Brazilian Population with Potential Cardiac and Neural Impact. J Mol Neurosci 48, 253–256 (2012). https://doi.org/10.1007/s12031-012-9768-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-012-9768-7